About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

New Molecular Chemotherapeutic Drug Targets Cancer Cells to Reduce Metastasis

by Preethi Sivaswaamy Mohana on February 26, 2018 at 11:55 AM
Font : A-A+

New Molecular Chemotherapeutic Drug Targets Cancer Cells to Reduce Metastasis

Chemotherapy drug paclitaxel can target and reduce the migrating cancer cells that are responsible for the development of tumor metastases, according to a study by a research team at the University of California, Riverside. The findings of the study are published in the Journal of Medicinal Chemistry.

Until now, paclitaxel has only been used to target rapidly dividing cancer cells. The team was successful in getting the drug to piggyback on 123B9, an agent they devised to target an oncogene called EphA2 (ephrin type-A receptor 2). EphA2 spreads cancer by allowing malignant cells to migrate from the primary tumor into circulation and eventually to adhere to other tissues.

Advertisement


"Once this novel tumor-homing agent binds to the EphA2 receptor, the oncogene functions as a cancer-specific molecular Trojan horse for paclitaxel, carrying the drug inside the cancel cell, killing the cell, and thwarting metastasis," said Maurizio Pellecchia, a professor of biomedical sciences at UCR's School of Medicine who led the research. "Without the targeting agent, paclitaxel cannot hitch a ride on EphA2."

Tumor metastasis is a leading cause of patient morbidity and mortality, and no treatments are currently available that specifically target metastasis formation. Cancer cells depend on a number of oncogenes, like EphA2, to form metastasis, the medical term for cancer spreading from the primary site to other regions in the body, accomplished when cancer cells break away from the primary site, travel through the blood or lymph system, and form new tumors elsewhere in the body.
Advertisement

Pellecchia and his colleagues found that when 123B9 binds to the extracellular region of the EphA2 receptor expressed in cancer cells, it causes the oncogene to internalize and degrade inside the cell, thus preventing cancer cells from entering circulation and metastasizing.

"Because this binding causes EphA2 internalization, we also sought to conjugate 123B9 with paclitaxel and thus direct the drug to migrating cancer cells," said Pellecchia, who holds the Daniel Hays Chair in Cancer Research at UCR.

Recent collaborative work between UCR and Cedars-Sinai Medical Center in Los Angeles demonstrated that in animal models of human breast cancer, mice treated with 123B9 that was conjugated with paclitaxel had significantly fewer circulating cancer cells in the blood compared to mice that were not treated or even treated with paclitaxel alone.

"Our work predicts that reducing the number of circulating cancer cells produces less metastasis," Pellecchia said. "Indeed, in a second tumor model of metastatic breast cancer, we demonstrated that mice treated with the EphA2-targeting paclitaxel conjugate presented nearly no lung metastases, while a large numbers of lesions were observed in both untreated mice and in mice treated with just paclitaxel."

Pellecchia said the road to a therapeutic for human trials is still long and includes the iterative design and synthesis of more potent and selective agents.

"Nonetheless, the proof of concept studies we have obtained thus far are extremely encouraging, and we are confident that with proper support and efforts we could translate our findings into experimental therapeutics for a variety of solid tumors that are driven by EphA2 overexpression, including breast, lung, prostate, pancreatic, and ovarian cancers," said Pellecchia, who serves as the founding director of the Center for Molecular and Translational Medicine at UCR.

He noted that while these studies solidify UCR's partnership with Cedars-Sinai Medical Center, the research team moving forward is expanding. Already, it includes UCR's Jikui Song, an assistant professor of biochemistry, and Dr. Samar Nahas, an assistant clinical professor of gynecology and oncology in the School of Medicine.



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Effect of Blood Group Type on COVID-19 Risk and Severity
Woman with Rare Spinal Cord Defect from Birth Sues Doctor
Toothache
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Cancer and Homeopathy Parkinsons Disease Surgical Treatment Colorectal Cancer Signature Drug Toxicity Cancer Facts Cancer Tattoos A Body Art Drugs Banned in India Common Lifestyle Habits that Cause Diseases 

Recommended Reading
Brain Tumor
Brain tumors are the abnormal growth of brain cells that may be benign or metastatic. Brain tumors ....
Zika Virus: The New Treatment For Brain Tumor
When infected with Zika virus, brain tumor cells form metabolites such as digoxin, a molecule that ....
Tumor Progression Due to Communication Between Lung Tumors and Bones
General study identifying interaction among tumor cells, bone marrow and immune cells opens new ......
Controlling Gene Expression may Stop Tumor Growth in Ewing Sarcoma
Ewing sarcoma may be treated effectively by controlling the expression of the genes EWS and FLI-1. ....
Colorectal Cancer
Colorectal cancer is a cancer that starts in the colon or the rectum. Colorectal cancer is the third...
Common Lifestyle Habits that Cause Diseases
Cigarette smoking, unhealthy diets, overuse of alcohol, and physical inactivity are some of the most...
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...
Drugs Banned in India
Several drugs are either banned or withdrawn after introduction in the market....
Tattoos A Body Art
Tattoos are a rage among college students who sport it for the ‘cool dude’ or ‘cool babe’ look...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use